Aspirin May Reduce Bowel Cancer Risk for Lynch Syndrome Patients
Table of Contents
By Alice Roberts | LONDON – 2025/06/24 07:54:46
A new proposal suggests that a low dose of aspirin could significantly reduce the risk of bowel cancer in individuals with Lynch syndrome. According to PROF BURN, health regulators should advise that the lowest possible dose of aspirin be administered to thes patients, despite the potential bleeding risks in some individuals.
The research indicates a considerable benefit. “Roughly speaking, if someone with Lynch syndrome has about a 2% a year chance of getting mostly bowel cancers, we think if they take aspirin, that is halved – down to about 1% a year,” he explained.
PROF BURN emphasized that identifying those unaware they have Lynch syndrome is the next critical step. He noted that “about 150,000 patients in the UK” have the condition, with many only being diagnosed after cancer appears in their family history. “It was only when they get cancer in their 40s and 50s, and remember their auntie had cancer, and their granddad.”
Identifying Undiagnosed Cases
“Roughly speaking, if someone with Lynch syndrome has about a 2% a year chance of getting mostly bowel cancers, we think if they take aspirin, that is halved.”
The challenge remains in detecting the undiagnosed population, allowing for proactive preventative measures.
Frequently Asked Questions
- What is Lynch syndrome?
- Lynch syndrome is an inherited condition that increases the risk of certain cancers, including colorectal, endometrial, and ovarian cancers.
- How does aspirin help prevent cancer in Lynch syndrome patients?
- Aspirin’s anti-inflammatory properties may interfere with cancer development, reducing the risk of colorectal cancer in individuals with Lynch syndrome.
- What is the recommended aspirin dosage for Lynch syndrome patients?
- PROF BURN recommends the lowest possible dose of aspirin to minimize the risk of bleeding.
